Skip to content

Family history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives.

Paut Greebe, Jacoline E. C. Bromberg, Gabriël J.E. Rinkel, Ale Algra, Jan van Gijn

Journal of Neurology Neurosurgery & Psychiatry · 1997 · 4,156 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Greebe, P., Bromberg, J. E. C., Rinkel, G. J., Algra, A., & Gijn, J. van. (1997). Family history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives. Journal of Neurology Neurosurgery & Psychiatry, 62(3), 273–275. https://doi.org/10.1136/jnnp.62.3.273

In text: (Greebe et al., 1997)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

OBJECTIVE AND METHODS: To assess the validity of the family history obtained at the bedside of patients with recent subarachnoid haemorrhage by subsequently contacting all first and second degree relatives, with verification from medical record data. RESULTS: In a prospectively collected series of 163 patients with recent subarachnoid haemorrhage the history or cause of death could be ascertained in 1259 (98%) of the first degree relatives and in 3038 (85%) of the second degree relatives. For first degree relatives only, the sensitivity of the family history at the bedside was 0.75 (95% confidence interval (95% CI) 0.35-0.97) and the positive predictive value was 0.55 (95% CI 0.23-0.83); for first and second degree relatives together the sensitivity was 0.58 (95% CI 0.28-0.85) and the positive predictive value was 0.64 (95% CI 0.31-0.89). CONCLUSION: The accuracy of the family history taken at the bedside is modest; a more thorough collection of data is crucial if the decision is taken to screen relatives based on the family history.

  1. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.1993
  2. Tissue Plasminogen Activator for Acute Ischemic Stroke1995
  3. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke2008
  4. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease2012
  5. Vascular Contributions to Cognitive Impairment and Dementia2011

Metadata from OpenAlex (CC0). Citations are generated from the published record.